214 related articles for article (PubMed ID: 30312286)
1. New Medicare Diabetes Prevention Coverage May Limit Beneficiary Access and Widen Health Disparities.
Ritchie ND; Gritz RM
Med Care; 2018 Nov; 56(11):908-911. PubMed ID: 30312286
[TBL] [Abstract][Full Text] [Related]
2. Medicare Diabetes Prevention Program: where are the suppliers?
Ritchie ND; Sauder KA; Gritz RM
Am J Manag Care; 2020 Jun; 26(6):e198-e201. PubMed ID: 32549070
[TBL] [Abstract][Full Text] [Related]
3. Enhancing access and impact of the Medicare Diabetes Prevention Program using telehealth: a narrative review.
Ritchie ND; Turk MT
Mhealth; 2024; 10():10. PubMed ID: 38323146
[TBL] [Abstract][Full Text] [Related]
4. Stakeholder analysis: Medicare Diabetes Prevention Program awareness and implementation.
Turk MT; Ritchie ND; Jakub K
Am J Manag Care; 2023 Jun; 29(6):308-312. PubMed ID: 37341978
[TBL] [Abstract][Full Text] [Related]
5. Estimated number of eligible Part B beneficiaries for the medicare diabetes prevention program at the county level and by urban-rural classification.
Ng BP; Cheng YJ; Rutledge S; Cannon MJ; Zhang P; Smith BD
PLoS One; 2020; 15(11):e0241757. PubMed ID: 33170867
[TBL] [Abstract][Full Text] [Related]
6. Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.
Ritchie ND; Kaufmann PG; Gritz RM; Sauder KA; Holtrop JS
Am J Health Promot; 2019 Feb; 33(2):289-292. PubMed ID: 29986597
[TBL] [Abstract][Full Text] [Related]
7. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
[TBL] [Abstract][Full Text] [Related]
8. Medicare Beneficiaries' Perspectives on the Quality of Hospital Care and Their Implications for Value-Based Payment.
Trenaman L; Harrison M; Hoch JS
JAMA Netw Open; 2023 Jun; 6(6):e2319047. PubMed ID: 37342041
[TBL] [Abstract][Full Text] [Related]
9. Supplemental Text Message Support With the National Diabetes Prevention Program: Pragmatic Comparative Effectiveness Trial.
Ritchie ND; Gutiérrez-Raghunath S; Durfee MJ; Fischer H
JMIR Mhealth Uhealth; 2020 Jun; 8(6):e15478. PubMed ID: 32554385
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.
Chen F; Su W; Becker SH; Payne M; Castro Sweet CM; Peters AL; Dall TM
PLoS One; 2016; 11(10):e0163627. PubMed ID: 27706216
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Cost of Caring for Medicare Beneficiaries in Federally Funded Health Centers to Other Care Settings.
Mukamel DB; White LM; Nocon RS; Huang ES; Sharma R; Shi L; Ngo-Metzger Q
Health Serv Res; 2016 Apr; 51(2):625-44. PubMed ID: 26213167
[TBL] [Abstract][Full Text] [Related]
12. The Value-Based Payment Modifier: Program Outcomes and Implications for Disparities.
Roberts ET; Zaslavsky AM; McWilliams JM
Ann Intern Med; 2018 Feb; 168(4):255-265. PubMed ID: 29181511
[TBL] [Abstract][Full Text] [Related]
13. Enrolling people with prediabetes ages 60-64 in a proven weight loss program could save Medicare $7 billion or more.
Thorpe KE; Yang Z
Health Aff (Millwood); 2011 Sep; 30(9):1673-9. PubMed ID: 21900657
[TBL] [Abstract][Full Text] [Related]
14. The Financial Effect of Medicare Coverage Design and Safety Net Options for Cancer Care.
Bethay SS; Travis MJ; Batt SK; Bochenek SH; Schwieterman PA
J Manag Care Spec Pharm; 2020 Jan; 26(1):76-80. PubMed ID: 31880225
[TBL] [Abstract][Full Text] [Related]
15. Association Between Patient Cognitive and Functional Status and Medicare Total Annual Cost of Care: Implications for Value-Based Payment.
Johnston KJ; Wen H; Hockenberry JM; Joynt Maddox KE
JAMA Intern Med; 2018 Nov; 178(11):1489-1497. PubMed ID: 30242381
[TBL] [Abstract][Full Text] [Related]
16. Participant Satisfaction and Perceptions About Program Impact in the Medicaid Incentives for Prevention of Chronic Disease Pilot Program.
Treiman KA; Teixeira-Poit S; Li L; Tardif-Douglin M; Gaines J; Hoerger T
Am J Health Promot; 2019 Mar; 33(3):381-390. PubMed ID: 30012014
[TBL] [Abstract][Full Text] [Related]
17. Medicare underpayment for Diabetes Prevention Program: implications for DPP suppliers.
Parsons AS; Raman V; Starr B; Zezza M; Rehm CD
Am J Manag Care; 2018 Oct; 24(10):475-478. PubMed ID: 30325189
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Prior Authorization in Medicare Nonemergent Ambulance Transport.
Contreary K; Asher A; Coopersmith J
JAMA Health Forum; 2022 Jul; 3(7):e222093. PubMed ID: 35977218
[TBL] [Abstract][Full Text] [Related]
19. Effect of Medicare advantage payments on dually eligible Medicare beneficiaries.
Atherly A; Dowd BE
Health Care Financ Rev; 2005; 26(3):93-104. PubMed ID: 17290630
[TBL] [Abstract][Full Text] [Related]
20. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
